Phospho-AKT1 (S124) Antibody

What is the biological significance of AKT1 S124 phosphorylation?

Functionally, S124 phosphorylation appears to be important for optimal AKT1-mediated cellular processes. The S124A mutation modestly decreases cell invasion capabilities compared to wild-type AKT1, indicating its role in regulating cellular behaviors associated with cancer progression . Additionally, under basal conditions, S124A mutation reduces phosphorylation of PRAS40, a known AKT substrate, suggesting that S124 phosphorylation may influence AKT1's kinase activity toward specific targets .

How does S124 phosphorylation differ from other well-characterized AKT1 phosphorylation sites?

Unlike the extensively studied phosphorylation sites Thr308 and Ser473, which are directly involved in AKT1 activation in response to growth factors and insulin, S124 phosphorylation appears to have more nuanced regulatory functions. While Thr308 and Ser473 phosphorylation are primarily induced by stimuli such as insulin, S124 phosphorylation may be constitutive or regulated through different mechanisms .

Interestingly, AKT1 S124A mutation affects the phosphorylation pattern more extensively than would be predicted from loss of a single phosphorylation site. This suggests that S124 phosphorylation might serve as a priming event that facilitates subsequent phosphorylation of other sites, or that it induces conformational changes affecting multiple phosphorylation events .

How do the functions of phosphorylated AKT1 S124 compare across different tissues and cell types?

Phosphorylated AKT1 S124 has been detected across various tissues and cell types, including human fetal brain, human fetal kidney, mouse brain, rat brain, rat heart, RAW 264.7 (mouse macrophage cells), and PC-12 (rat adrenal gland pheochromocytoma) cells . This broad expression pattern suggests that S124 phosphorylation may have conserved functions across different tissues.

What are the optimal methods for validating phospho-AKT1 (S124) antibody specificity?

Validating the specificity of phospho-AKT1 (S124) antibodies requires multiple complementary approaches:

• Phosphatase treatment: Treating cell lysates with alkaline phosphatase or other specific phosphatases should eliminate the signal detected by the phospho-specific antibody, confirming that the antibody recognizes the phosphorylated form of the protein. This approach has been demonstrated with MCF7 cell lysates, where alkaline phosphatase treatment abolished the antibody signal .

• Mutant expression: Comparing antibody reactivity between wild-type AKT1 and the S124A mutant in a clean background (such as AKT1-/- cells) provides powerful validation. The antibody should recognize wild-type AKT1 but not the S124A mutant when both are expressed at comparable levels .

• Stimulus-dependent phosphorylation: If S124 phosphorylation is regulated by specific stimuli, demonstrating changes in antibody signal following relevant treatments can support specificity.

• Peptide competition: Using phosphorylated versus non-phosphorylated peptides containing the S124 site to compete for antibody binding can confirm phospho-specificity.

• Knockdown/knockout validation: Analyzing antibody reactivity in AKT1 knockdown or knockout cells compared to wild-type cells can confirm isoform specificity.

What are the optimal experimental conditions for detecting AKT1 S124 phosphorylation by Western blot?

For optimal detection of phosphorylated AKT1 S124 by Western blot:

• Sample preparation: Samples should be prepared with phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate) to preserve phosphorylation status.

• Blocking conditions: 5% non-fat dry milk (NFDM) in TBST has been effectively used as blocking and diluting buffer for phospho-AKT1 (S124) antibodies .

• Antibody dilution: Effective dilutions range from 1/1000 to 1/10000 depending on the specific antibody and sample type .

• Band identification: The expected molecular weight for AKT1 is approximately 55 kDa, though the observed band often appears at around 56 kDa in SDS-PAGE .

• Controls: Include positive controls (tissues/cells known to express phosphorylated AKT1) and negative controls (phosphatase-treated samples or AKT1 knockout samples).

• Detection system: Enhanced chemiluminescence (ECL) systems with appropriate exposure times (typically 3-15 minutes depending on signal strength) have been successfully used .

How can phospho-AKT1 (S124) antibodies be effectively used in immunoprecipitation experiments?

For effective immunoprecipitation (IP) of phosphorylated AKT1 S124:

• Antibody selection: Use antibodies specifically validated for IP applications. Both monoclonal and polyclonal antibodies against phospho-AKT1 (S124) can be suitable for IP, though they may have different efficiencies .

• Lysis conditions: Use non-denaturing lysis buffers containing phosphatase inhibitors to preserve phosphorylation while maintaining protein structure.

• Pre-clearing: Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Antibody incubation: Incubate cell lysates with the phospho-AKT1 (S124) antibody overnight at 4°C to allow complete antigen binding.

• Sequential IP approach: For studies requiring distinction between different phosphorylated forms of AKT1, consider sequential IP approaches where one phospho-specific antibody is used for the first IP, followed by another phospho-specific antibody for the second IP.

• Validation of IP specificity: Confirm specificity by immunoblotting the immunoprecipitated material with alternative AKT1 antibodies or by mass spectrometry analysis.

How does S124 phosphorylation coordinate with other AKT1 phosphorylation sites in response to different cellular stimuli?

AKT1 contains at least 22 potential phosphorylation sites, creating a complex regulatory network. Research indicates that the coordination between S124 phosphorylation and other sites varies depending on cellular conditions and stimuli:

• Basal conditions: Under serum starvation, AKT1 exists in multiple phosphorylated forms with distinct isoelectric points, suggesting coordinated phosphorylation of different residues, including S124 and T450 .

• Insulin stimulation: Insulin treatment induces changes in AKT1 phosphorylation patterns, including enhanced phosphorylation at T308 and S473. Interestingly, mutation of S473 affects insulin-induced phosphorylation of other sites, suggesting a hierarchical relationship between phosphorylation events .

• Relationship with T450 phosphorylation: T450 phosphorylation in the turn motif occurs co-translationally and is present on most AKT1 molecules, including those phosphorylated at S124. This suggests that T450 and S124 phosphorylation may coordinate to regulate AKT1 stability and function .

• Coordinate regulation: Nanofluidic proteomic immunoassay (NIA) studies have revealed that AKT1 exists in at least 12 distinct peaks with different isoelectric points, representing various combinations of phosphorylation events on individual AKT1 molecules . These patterns change upon stimulation, indicating dynamic coordination between different phosphorylation sites.

What are the methodological approaches to distinguish between AKT isoform-specific phosphorylation at S124?

Distinguishing between phosphorylation of specific AKT isoforms at similar residues requires sophisticated methodological approaches:

• Isoform-specific antibodies: Use antibodies that specifically recognize phosphorylated S124 in AKT1 but not equivalent sites in AKT2 or AKT3. Validation should include testing on samples expressing only specific AKT isoforms (e.g., AKT1-/- or AKT2-/- cells) .

• Isoelectric focusing combined with immunodetection: Nanofluidic proteomic immunoassay (NIA) can separate AKT isoforms based on their distinct isoelectric points, allowing visualization of isoform-specific phosphorylation patterns when combined with phospho-specific antibodies .

• Knockout cell models: Utilize AKT isoform-specific knockout cell lines (e.g., AKT1-/-, AKT2-/-, or AKT1-/-AKT2-/- cells) to isolate and study individual isoforms without interference from other family members .

• Mass spectrometry approaches: Employ targeted mass spectrometry with isoform-specific peptides surrounding the S124 site to quantitatively assess phosphorylation levels across different AKT isoforms.

• Phosphoproteomics combined with isoform-specific immunoprecipitation: Immunoprecipitate specific AKT isoforms followed by phosphoproteomic analysis to map all phosphorylation sites present on that particular isoform.

How can phospho-AKT1 (S124) status be accurately quantified in heterogeneous tissue samples?

Quantifying phospho-AKT1 (S124) in heterogeneous tissue samples presents several challenges that can be addressed through these methodological approaches:

• Tissue microdissection: Use laser capture microdissection to isolate specific cell populations from heterogeneous tissues before analysis of phospho-AKT1 (S124).

• Multiplexed immunohistochemistry/immunofluorescence: Combine phospho-AKT1 (S124) antibodies with cell type-specific markers to assess phosphorylation levels in distinct cell populations within intact tissue.

• Normalization strategies: Normalize phospho-AKT1 (S124) signals to total AKT1 levels and to housekeeping proteins to account for variations in protein loading and extraction efficiency.

• Rapid tissue preservation: Ensure rapid tissue preservation and processing with phosphatase inhibitors to prevent artifactual loss of phosphorylation during sample handling.

• Quantitative immunoblotting: Use standard curves with recombinant phosphorylated proteins for accurate quantification by immunoblotting.

• ELISA and bead-based multiplex assays: Develop sensitive assays for phospho-AKT1 (S124) that can be used for quantitative analysis of tissue lysates with small sample volumes.

What are common technical challenges when detecting phospho-AKT1 (S124) and how can they be overcome?

Researchers frequently encounter these challenges when working with phospho-AKT1 (S124) antibodies:

• Low phosphorylation levels: S124 phosphorylation may be present at lower levels compared to well-studied sites like T308 and S473.

  • Solution: Use sensitive detection methods such as enhanced chemiluminescence or fluorescent secondary antibodies, consider signal amplification systems, or immunoprecipitate AKT1 prior to phospho-detection to concentrate the target protein.

• Cross-reactivity with other phosphorylated proteins: Some phospho-specific antibodies may cross-react with similar phosphorylation motifs in other proteins.

  • Solution: Validate antibody specificity using AKT1 knockout or knockdown samples, and consider using multiple antibodies targeting different epitopes of phospho-AKT1 (S124).

• Rapid dephosphorylation during sample preparation: Phosphorylation can be lost during cell lysis and sample handling.

  • Solution: Include comprehensive phosphatase inhibitor cocktails in all buffers, maintain samples at cold temperatures, and process samples rapidly.

• Interfering post-translational modifications: Other post-translational modifications near S124 might interfere with antibody binding.

  • Solution: Use multiple antibodies with different epitopes surrounding the phospho-S124 site, or consider mass spectrometry approaches to detect and quantify the phosphorylation directly.

• Variability between antibody lots: Different production lots of the same antibody may show variability in specificity and sensitivity.

  • Solution: Validate each new antibody lot against previous lots, and maintain consistent positive and negative controls across experiments.

How should researchers design experiments to study the dynamics of AKT1 S124 phosphorylation?

To effectively study the dynamics of AKT1 S124 phosphorylation:

• Time-course experiments: Design detailed time-course studies following stimulation with growth factors, insulin, or other relevant stimuli, sampling at both early (seconds to minutes) and late (hours) time points.

• Comparative analysis with other phosphorylation sites: Simultaneously monitor phosphorylation at S124, T308, S473, and T450 to understand the relationship between these events.

• Pharmacological interventions: Use kinase inhibitors, phosphatase inhibitors, and pathway-specific modulators to dissect the regulatory mechanisms controlling S124 phosphorylation.

• Genetic approaches: Employ CRISPR/Cas9 to create endogenous S124A mutations or phosphomimetic (S124D/E) mutations to study functional consequences.

• Live-cell imaging: Develop phospho-specific biosensors based on FRET or other technologies to monitor S124 phosphorylation dynamics in living cells.

• Single-cell analysis: Apply single-cell Western blotting or mass cytometry (CyTOF) with phospho-specific antibodies to capture cell-to-cell variability in S124 phosphorylation.

• Mathematical modeling: Develop computational models incorporating S124 phosphorylation to predict its regulatory role within the broader AKT signaling network.

What controls should be included when studying AKT1 S124 phosphorylation in different experimental setups?

Robust experimental design for studying AKT1 S124 phosphorylation should include these controls:

• Phosphatase-treated samples: Treat duplicate samples with lambda phosphatase or alkaline phosphatase to demonstrate phospho-specificity of the antibody signal .

• AKT1 knockout/knockdown controls: Include AKT1-deficient samples to confirm antibody specificity for AKT1 versus other AKT isoforms .

• S124A mutant expression: Express the non-phosphorylatable S124A mutant as a negative control for phospho-specific antibody detection .

• Stimulus-responsive controls: Include samples treated with stimuli known to activate AKT signaling (e.g., insulin, growth factors) as positive controls for general AKT activation.

• Cross-species validation: When appropriate, include samples from multiple species to confirm conservation of the phosphorylation site and antibody cross-reactivity .

• Loading controls: Use total AKT1 antibodies in parallel with phospho-specific antibodies to normalize for variations in protein expression levels.

• Kinase inhibitor controls: Include samples treated with PI3K/AKT pathway inhibitors to demonstrate the dependence of the phosphorylation on the canonical signaling pathway.

How should researchers interpret changes in AKT1 S124 phosphorylation in relation to other AKT phosphorylation sites?

Interpreting changes in AKT1 S124 phosphorylation requires consideration of several factors:

• Relative dynamics: Compare the kinetics of S124 phosphorylation with those of T308 and S473 phosphorylation. Differences in the timing or persistence of phosphorylation events can provide insights into their regulatory relationships .

• Stimulus specificity: Determine whether S124 phosphorylation responds selectively to certain stimuli compared to other phosphorylation sites, which may indicate distinct regulatory pathways.

• Quantitative relationships: Assess whether changes in S124 phosphorylation correlate linearly or non-linearly with changes in T308/S473 phosphorylation or with AKT1 kinase activity.

• Isoform-specific patterns: Compare phosphorylation patterns between AKT1, AKT2, and AKT3 to identify isoform-specific regulatory mechanisms .

• Downstream consequences: Correlate changes in S124 phosphorylation with phosphorylation of AKT substrates and functional outcomes such as cell proliferation, survival, or metabolism .

• Coordinate regulation: Use methods like nanofluidic proteomic immunoassay to determine whether multiple phosphorylation events occur on the same AKT1 molecule or on different subpopulations .

What is the significance of AKT1 S124 phosphorylation in cancer research and potential therapeutic applications?

AKT1 S124 phosphorylation has several implications for cancer research and therapeutics:

• Biomarker potential: Changes in S124 phosphorylation patterns may serve as biomarkers for specific cancer types or for predicting response to PI3K/AKT pathway inhibitors.

• Resistance mechanisms: Alterations in S124 phosphorylation could contribute to resistance against AKT inhibitors that primarily target the ATP-binding pocket or allosteric sites.

• Isoform-specific targeting: Understanding the unique regulation of AKT1 via S124 phosphorylation may enable the development of isoform-selective therapeutic approaches, potentially reducing side effects associated with pan-AKT inhibition.

• Functional significance: S124 phosphorylation's role in regulating cell invasion suggests it may contribute to cancer progression and metastasis . Targeting the kinases or phosphatases that regulate S124 phosphorylation could offer novel therapeutic strategies.

• Combination therapies: The relationship between S124 phosphorylation and other phosphorylation events may inform rational combination therapies targeting multiple aspects of AKT regulation.

How can advanced phosphoproteomics approaches complement antibody-based detection of AKT1 S124 phosphorylation?

Phosphoproteomics approaches offer powerful complementary methods to antibody-based detection:

• Unbiased discovery: Mass spectrometry-based phosphoproteomics can identify novel phosphorylation sites or combinations of modifications on AKT1 that may interact functionally with S124 phosphorylation.

• Stoichiometry determination: Quantitative mass spectrometry can determine the proportion of AKT1 molecules phosphorylated at S124 under different conditions, providing insights into the extent of this modification.

• Multi-site analysis: Phosphopeptide enrichment followed by mass spectrometry can identify phosphorylation patterns on individual AKT1 molecules, revealing whether S124 phosphorylation co-occurs with other modifications.

• Kinase/phosphatase identification: Phosphoproteomic approaches combined with kinase inhibitor profiling or kinase/phosphatase knockdown can help identify the enzymes responsible for regulating S124 phosphorylation.

• Signaling network mapping: Global phosphoproteomic analysis can place S124 phosphorylation within the broader context of signaling networks, identifying potential cross-talk with other pathways.

• Validation of antibody specificity: Mass spectrometry can validate phospho-specific antibodies by confirming the presence and identity of the phosphorylated residue in immunoprecipitated samples.